Neurometabolites and Antipsychotic Response in Psychosis

Bridget King; Kirsten Borup Bojesen; Charlotte Crisp; Andrea de Bartolomeis; Lieuwe de Haan; Camilo de la Fuente-Sandoval; Kara Dempster; Richard J. Drake; Paola Dazzan; Bjørn H. Ebdrup; Lejia Fan; Ariel Graff-Guerrero; Birte Yding Glenthøj; Shiori Honda; Oliver Howes; Li-Chung Huang; Rene Kahn; James MacCabe; Marta Matrone; Kate Merritt; Meghan McIlwain; Philip McGuire; Shinichiro Nakajima; Stephen M. Lawrie; Lena Palaniyappan; Francisco Reyes-Madrigal; Bruce Russell; Akira Sawa; Sukhi Shergill; Krish D. Singh; Iris E. Sommer; James M. Stone; Junyu Sun; Sakiko Tsugawa; Fumihiko Ueno; Marieke van der Pluijm; Elsmarieke van de Giessen; James T. R. Walters; Kun Yang; Yen Kuang Yang; Matthew J. Kempton; Alice Egerton

Journal Article

Neurometabolites and Antipsychotic Response in Psychosis

King B
Bojesen K
Crisp C
et al.

JAMA Psychiatry (2026)

DOI: 10.1001/jamapsychiatry.2026.1674

0Citations

4Readers

Get full text

Abstract

IMPORTANCE: Revealing neurobiological markers of antipsychotic nonresponse in psychosis may aid outcome prediction and inform novel treatment targets.

Cite

CITATION STYLE

APA

King, B., Bojesen, K. B., Crisp, C., de Bartolomeis, A., de Haan, L., de la Fuente-Sandoval, C., … Egerton, A. (2026). Neurometabolites and Antipsychotic Response in Psychosis. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2026.1674

Neurometabolites and Antipsychotic Response in Psychosis

Abstract

Cite

Register to see more suggestions